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AcetoneextractsofselectedplantspecieswereevaluatedfortheirinvitrocytotoxicityagainstanoncancerousAfricangreenmonkey
kidney (Vero) cell line and an adenocarcinoma cervical cancer (HeLa) cell line. The plants studied were Origanum vulgare L.
(Oregano), Rosmarinus oﬃcinalis L. (Upright and ground cove rosemary), Lavandula spica L. (Lavender), Laurus nobilis L. (Bay
leaf), Thymus vulgaris L. (Thyme), Lavandula x intermedia L. (Margaret Roberts Lavender), Petroselinum crispum Mill. (Curly
leaved parsley), Foeniculum vulgare Mill. (Fennel), and Capsicum annuum L. (Paprika). Antioxidant activity was determined using
a quantitative DPPH (1,1-diphenyl-2-picryl hydrazyl) assay. The rosemary species exhibited eﬀective radical scavenging capacity
with 50% inhibitory concentration (IC50)o f3 .48 ± 0.218μg/mL and 10.84 ± 0.125μg/mL and vitamin C equivalents of 0.351g
and 1.09g for McConnell’s Blue and Tuscan Blue, respectively. Cytotoxicity was measured using XTT (Sodium 3 -[1-(phenyl
amino-carbonyl)-3,4-tetrazolium]-bis-[4-methoxy-6-nitro] benzene sulfonic acid hydrate) colorimetric assay. Only L. nobilis and
O. vulgare exhibited pronounced eﬀects on the HeLa cell line. Dose-dependent studies revealed IC50 of 34.46 ± 0.48μg/mL and
126.3±1.00μg/mLontheHeLacellsandontheVerocells124.1μg/mL ±18.26and163.8μg/mL ±2.95forL.nobilisandO. vulgare,
respectively. Light (eosin and haematoxylin staining) and confocal microscopy (Hoechst 33342, acridine orange, and propidium
iodide staining) were used to evaluate the cytotoxic mechanism of action for L. nobilis and O. vulgare.
1.Introduction
South Africa has a remarkable ﬂoral and cultural diversity
with an estimate of 30,000 species of higher plants, which
are mostly endemic to the region. A great number of these
species are used for traditional medicinal purposes where
Zulu traditional healers use around 1032 diﬀerent species
from 147 various plant families [1]. It is estimated that
around 27 million South African citizens rely on these
traditional medicines for their primary health care needs due
to the inaccessibility of western medicine to some regions
and the high cost [2]. Therefore, the demand for traditional
medicines remains high in rural parts [1].
According to the World Health Organization (WHO)
canceris one of the leading causesof deathworldwide, which
accountedfor7.6milliondeaths(around13%)oftheworld’s
population in 2008. They have furthermore estimated that
the worldwide deaths are likely to rise to over 11 million
in 2030. The Cancer Association of South Africa (CANSA)
has estimated that one in every six South African males and
one in every seven South African females are diagnosed with
cancer. One of the most prevalent types of cancer found
in South African females is cervical cancer which is also
the most widespread cancer found in South African black
women and in poor-income countries.
Cervical cancer is caused by the Human Papilloma Virus
(HPV) which forms warts in the throat and genital area.
Although it is the most prevalent cancer in South African
black women it is also the most preventable cancer through
screening and treatment of precancerous lesion and the
use of vaccines. Natural products are being tested for the
treatment of cancer as conventional cancer treatments such
as chemotherapy destroy cancerous as well as healthy cells.
In South Africa the use of plants for the treatment of
cancer is not common [3]. There is, however, a Southern
African plant currently undergoing clinical trials for the2 Evidence-Based Complementary and Alternative Medicine
treatment of cancer. The plant is Combretum caﬀrum,m o r e
commonly known as the “bush willow” which causes the
shutdown of tumours and tumour necrosis [4]. Herbs and
spices have been used for thousands of years as medicines.
Through scientiﬁc research it is indicated that the bioactive
components present in herbs and spices can reduce the
risk of cancer through their antimicrobial, antioxidant,
and antitumorogenic activity and their ability to directly
suppress carcinogen bioactivation [5]. In this study common
herbs and spices were tested for their cytotoxic activity on
cervical cancer (HeLa) cells. These plants were chosen as
they are readily available in South Africa and because they
are traditionally used all over Africa. This study will be
used as a comparative study on future research which will
focus mainly on indigenous South African plants and their
cytotoxic activity on cervical cancer cells.
2.MaterialsandMethods
2.1. Chemicals and Reagents. DPPH, ascorbic acid, Bouin’s
ﬁxative,haematoxylin,eosin,xylene,Hoechst33342,propid-
ium iodide, and N-propyl-gallate were of analytical grade
and supplied by Sigma Aldrich (St. Louis, MO, USA). All
cell lines, media, trypsin-EDTA, fetal bovine serum (FBS),
phosphate buﬀer saline (PBS), antibiotics, and glycerol were
supplied by Highveld Biological (Pty) Ltd. (Modderfontein,
Johannesburg, RSA).
2.2. Plant Material. All plant material was collected during
February 2011 in Pretoria, Gauteng. The plants were identi-
ﬁed by the University of Pretoria Botanical Garden curator,
Jason Sampson. The collected aerial parts of the plants were
shade-dried for two weeks.
2.3. Preparation of Acetone Extracts. The air-dried aerial
partsoftheplantweremechanicallygroundtoproduceaﬁne
powder. The weighed samples were extracted with acetone
for48handthereafterfor24husingfreshsolvent.Thesolute
of each plant was ﬁltered with a Buchner funnel. Thereafter
the menstruum was evaporated to dryness using a vacuum
rotary evaporator to give a dark green extract.
2.4. Antioxidant Activity—DPPH Assay. The method of du
Toit et al. [6] was followed to determine the radical scav-
enging capacity (RSC) of the extracts. Slight modiﬁcations
to the method were made and are described brieﬂy. Stock
solutions of vitamin C and the extracts were prepared at
concentrations of 2mg/mL and 10mg/mL, respectively. To
each well in the top row of a 96-well plate, 200μLo f
distilled water was added. To the rest of the wells 110μLo f
distilled water was added as a medium. Twenty microlitres of
extract was added to the ﬁrst top wells, in triplicate, followed
by serial dilution with ﬁnal concentrations ranging from
3.9μg/mL to 500μg/mL for the extracts and 0.781μg/mL to
100μg/mL for vitamin C [7]. Finally 90μLo f0 . 0 4MD P P H
ethanolic solution was added to each well, except for the
negativecontrolwheredistilledwaterwasaddedinstead.The
plates were left in a dark room to develop for 30 minutes.
The RSC of the extracts was determined using a BIO-TEK
Power-Wave XS multiplate reader at a wavelength of 515nm,
using KC junior software. The IC50 values of each extract
were calculated using GraphPad Prism 4 software. Lastly,
the vitamin C equivalent for each extract was calculated
as follows: (IC50 of extract × 200mg vitamin C)/IC50 of
vitamin C.
2.5. Cell Culture. The HeLa and Vero cell lines were
maintained in culture ﬂasks containing Eagle’s Minimum
Essentail Medium supplemented with 10% heat-inactivated
FBS and 1% antibiotics (100U/mL penicillin, 100μg/mL
streptomycin and 250μg/mL fungizone). The cells were
grownat37◦Cinahumidiﬁedincubatorsetat5%CO2.Cells
were subcultured after they formed a monolayer on the ﬂask.
The cells were detached by treating them with trypsin-EDTA
(0.25% trypsin containing 0.01% EDTA) for 10 minutes and
then by adding complete medium to inhibit the reaction.
2.6. In Vitro Cytotoxicity Assay. Cytotoxicity was measured
by the XTT method using the Cell Proliferation Kit II. The
method described by Zheng et al. [8]w a su s e dt op e r f o r m
the assay. Both HeLa and Vero cells were seeded (100μL) in
a 96-well microtitre plate (concentration 1 × 105 cells/mL).
The plate was then incubated for 24h at 37◦C and 5% CO2
to allow the cells to attach to the bottom of the wells. The
extracts were each prepared to a stock solution of 20mg/mL
and added to the microtitre plate. Serial dilutions were made
to range from a concentration of 400μg/mL–1.563μg/mL
for each extract. The microtitre plate was incubated for a
further 72h. The control wells included vehicle-treated cells
exposed to 2% DMSO (sample concentration of 400μg/mL)
and the positive control Actinomycin D with concentrations
ranging between 0.5μg/mL and 0.002μg/mL. After the 72h
incubation period, the XTT reagent (50μL) was added to
a ﬁnal concentration of 0.3mg/mL and the plate was then
further incubated for another 2 hours. After the incubation
the absorbance of the colour complex was read at 490nm
with a reference wavelength set at 690nm using a BIO-
TEK Power-Wave XS multiwell plate reader. The assay was
performed in triplicate to calculate an IC50 of the cell
population for each extract. The results were analysed using
the GraphPad Prism 4 program.
2.7. Light Microscopy (Haematoxylin and Eosin Staining).
The cancerous HeLa cells were exposed to 34.46μg/mL
(IC50) and 68.92μg/mL (2IC50) of the Laurus nobilis extract
and 126.3μg/mL (IC50) and 252.6μg/mL (2IC50)o ft h e
Origanum vulgare extract. The Vero cells were exposed to
concentrations of 124.1μg/mL (IC50), 248.2μg/mL (2IC50)
and 34.46μg/mL (HeLa IC50)f o rLaurus nobilis and con-
centrations of 163.8μg/mL (IC50), 327.6μg/mL (2IC50),
and 126.3μg/mL (HeLa IC50)f o rOriganum vulgare.T h e
concentrations were chosen due to their antiproliferative
activity that was observed at these concentrations. Cells
were seeded at 100,000 cells per well in a 6-well plate
on heat-sterilized cover slips and incubated for 24h at
37◦Ca t5 %C O 2 for cell adherence. The cells were thenEvidence-Based Complementary and Alternative Medicine 3
exposed to the above concentrations including a vehicle-
treated control (2% DMSO), actinomycin D (0.05μg/mL) as
well as cells propagated in growth medium. The cells were
i n c u b a t e df o raf u r t h e r7 2 ha t3 7 ◦C. After 72h the cells
were ﬁxed with Bouin’s ﬁxative for 30min and stained by
standard haematoxylin and eosin procedures [9]. Brieﬂy, the
cells were rinsed in 70% ethanol for 20min and thereafter
stained in haematoxylin for a further 20min. The cells were
rinsed again and stained for 2min in 1% eosin solution.
After several rinsing procedures with diﬀerent percentages
of ethanol, the cells were left in xylene for 10min. The
cover slips were mounted to the microscope slides with the
remaining resin and evaluated using a Nikon Stereo Light
microscope equipped with a 1.4 Apo oil lens under 400x
magniﬁcation.
2.8. Confocal Microscopy (Hoechst 33342 and Propidium
Iodide Staining). A double ﬂuorescent dye staining method
was used according to Stander et al. [9]. Exponentially
growing cells were seeded at 100,000 cells per well in a
6-well plate onto heat-sterilized cover slips and incubated
for 24h at 37◦C and 5% CO2 to allow the cells to attach.
After the incubation period the medium was discarded and
the cells were exposed to the same concentrations as used
in Section 2.7 and incubated for a further 72h. After 72h
the treatment was inhibited by discarding the extract and
washing the cells with PBS. The cells were stained with
0.5mL of Hoechst 33342 solution (3.5μg/mL in PBS) and
incubated for 30min at 37◦C incubator. After 30min the
Hoechst 33342 solution was discarded and the cells were
then stained with 0.5mL of propidium iodide (40μg/mL in
PBS) and incubated for a further 5min at 37◦C. Thereafter
the cover slips were mounted on microscope slides with
mounting ﬂuid (90% glycerol, 4% N-propyl-gallate, 6%
PBS) and observed under a confocal microscope (ZEISS,
LSM 510 Meta confocal) using 1000x magniﬁcation.
Microscopy studies were done in triplicate so that the
appearance of apoptosis or normal cell proliferation could
be conﬁrmed. An alternative is that blind sampling can be
done whereby microscope slides are numbered and viewed
underthemicroscopewithoutknowingwhichtreatmentwas
appliedandthereafterconﬁrmingwhichtreatmentwasdone.
3. Results andDiscussion
3.1. Determination of Antioxidant Activity. All extracts
showeddose-dependentresponseswithconcentrationsrang-
ing from 500μg/mL to 3.90μg/mL. The highest inhibi-
tion was shown at 500μg/mL and the least inhibition at
3.90μg/mL. The rosemary species showed the most eﬀective
R S Ca sr e c o r d e di nTable 1. Bubonja-Sonje et al. [10]
conducted a study on the extracts of Rosmarinus oﬃcinalis
L. to test for their free radical scavenging activity of
DPPH. These extracts of rosemary were prepared from a
methanol:water:acetic acid (90:9:1, v/v/v) solvent. The
antioxidant content was attributed to the fact that rosemary
contained a very rich source of polyphenolic compounds,
more speciﬁcally phenolic diterpenes, such as Carnosol and
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Figure 1: Comparison of the IC50 values and the Vitamin C
equivalents of the plant extracts.
Carnosic acid. Speciﬁcally carnosic acid was tested for its
antioxidant activity and was determined to have an IC50
valueof27.3±5.2μg/mL.Inthepresentstudytheantioxidant
activity of the McConnell’s Blue and Tuscan Blue extracts
were found to be better than that of the rosemary extract
investigated by Bubonja-Sonje et al. [10]. The lavender
species showed minimal inhibition of DPPH for both for
Lavandula x intermedia and Lavandula spica. In a study
conducted by G¨ ulc ¸in et al. [11] aerial parts of the plant
Lavandula stoechas L. were used to determine the free radical
scavengingactivity.Thispartoftheplantcontainedoleanolic
acid, ursolic acid, vergatic acid, β-sitosterol, α-amyrin, α-
amyrin acetate, lupeol, erythrodiol, ﬂavanoids, luteolin,
acacetin, and vitexin. They found that the ethanol extract
had an IC50 of 60μg/mL, which was notably much more
eﬀective than the IC50 values of Lavandula-x-intermedia and
Lavandula spica. As no previous studies have been reported
on the antioxidant content of Lavandula-x-intermedia and
Lavandula spica it is diﬃcult to determine whether the
compounds present in Lavandula stoechas L. are also present
in the extracts used in the present study. The other plant
materials had RSC ranging from good to relatively good
which can be seen in Table 1 and Figure 1 together with
the vitamin C equivalents for each extract. The vitamin C
equivalent is a measurement of the amount extract (g) that
would be needed to have a RSC that is equivalent to the
RSC of 200mg vitamin C. The vitamin C equivalents were
calculated according to the following equation: (IC50 extract
× 200mg vitamin C)/IC50 vitamin C. The positive control
vitamin C had an IC50 of 1.98 ±0.006μg/mL.
3.2. Cytotoxicity of Extracts. All plant materials were tested
fortheiranticanceractivityusingtheXTTcolorimetricassay.
The plant extracts were prepared and screened for their in
vitro cytotoxic eﬀects against HeLa and Vero cells. The assay
is based on the ability of living cells to reduce the yellow-
water soluble XTT into an insoluble formazan product [12].
TheIC50 valueswereusedtodeterminetheselectivityindexes4 Evidence-Based Complementary and Alternative Medicine
Table 1: A summary of the IC50 values of the plant extracts and their vitamin C equivalents.
Plant extracts IC50 values
(μg/mL) ± SD
Vitamin C equivalents for a
200mg capsule (in g)
(1) Rosmarinus oﬃcinalis (McConnell’s Blue) 3.48 ±0.22 0.351
(2) Rosmarinus oﬃcinalis (Tuscan Blue) 10.84 ±0.12 1.09
(3) Lavandula-x-intermedia (Margaret Roberts) 138.5 ±4.0 14.0
(4) Lavandula spica 125.5 ±1.8 12.67
(5) Origanum vulgare 26.43 ±1.58 2.67
(6) Petroselinum crispum 53.3 ±2.63 5.38
(7) Laurus nobilis 30.85 ±0.48 3.12
(8) Thymus vulgaris 36.13 ±0.85 3.65
(9) Foeniculum vulgaris 38.36 ±0.76 3.88
(10) Capsicum annuum (Paprika) 63.06 ±1.91 6.27
(11) Vitamin Ca 1.98 ±0.01 —
aPositive control for antioxidant assay.
Table 2: Summary of the IC50 values and selectivity indexes of the plant extracts.
Plant extracts HeLa ICa
50
(μg/mL) ± SD
Vero IC50
(μg/mL) ± SD SIb
Rosmarinus oﬃcinalis (McConnell’s Blue) >100 12.03 ±0.02 0.12
Rosmarinus oﬃcinalis (Tuscan Blue) 23.31 ±0.055 23.64 ±0.10 0.52
Lavandula-x-intermedia (Margaret Roberts) 182 ±1.53 1 .5 ±0.14 0.17
Lavandulaspica 98.99 ±1.28 26.3 ±0.64 0.27
Origanumvulgare 126.3 ±1.00 163.8 ±2.95 1.30
Petroselinumcrispum 172.7 ±0.25 105 ±0.50 0.61
Laurusnobilis 34.46 ±0.48 124.1 ±18.83 . 6 1
Thymusvulgaris >200 138.4 ±2.60 0.66
Foeniculumvulgare 129.7 ±2.05 85.37 ±5.26 0.66
Capsicum annuum (Paprika) >200 122.3 ±3.76 0.58
Actinomycin Dc 0.002 0.027 13.5
aFifty percent inhibitory concentration.
bSelectivity index.
cPositive control for cytotoxicity assay.
(SI) of each extract which represents the overall activity. SI
valueswerecalculatedasfollows:(IC50 ofVero/IC50 ofHeLa).
The cytotoxicity and SI of the ten plant extracts are shown in
Table 2.
Laurus nobilis and Rosmarinus oﬃcinalis (Tuscan Blue)
strongly inhibited the proliferation of the HeLa cells as seen
inTable 2.ThelowesttoxicitywasobservedfromtheThymus
vulgaris and Capsicum annuum (Paprika) extracts. All other
extracts had IC50 values ranging from 98.99 ± 1.28μg/mL to
182 ± 0.15μg/mL. The IC50 value of Origanum vulgare was
noted and was used in further mechanistic studies together
with Laurus nobilis. Actinomycin D, a known anticancer
agent, had an IC50 value of 0.002 ± 0.0000395μg/mL. The
toxicity on the Vero cells ranged from a high toxicity with an
IC50 value of 12.03 ± 0.02μg/mL for Rosmarinus oﬃcinalis
(McConnell’s Blue) to a low toxicity with an IC50 value of
163.8 ± 2.92μg/mL for Origanum vulgare. It is interesting
to note that the two rosemary species exhibited varying
cytotoxicity against the HeLa cells. The anticarcinogenic
activityofrosemaryisduetothemajorbioactivecompounds
such as rosmarinic acid, carnosic acid, and carnosol [13].
Tuscan blue rosemary could possibly have a higher concen-
tration of these bioactive compounds and therefore shows
higher toxicity on the HeLa cells. In a similar study where
compoundsextractedfromRosmarinusoﬃcinaliswere tested
on various cancer cell lines, such as NCI-H82 (small lung
carcinoma), DU-145 (prostate carcinoma), Hep3D (liver
carcinoma), K-562 (chronic myelois carcinoma), MCF-7,
(breast adenocarcinoma), PC-3 (prostate adenocarcinoma)
and MDA-MB-231 (breast adenocarcinoma) the IC50 values
ranged from 8.82μg/mL to over 100μg/mL [14]. The lowest
toxicity towards the HeLa cell line was seen in the Capsicum
annuumandThymusvulgarisextracts.Inanarticlepublished
by Cancer Research in Capsicum was reported to help in theEvidence-Based Complementary and Alternative Medicine 5
treatment of prostate cancer. Furthermore the essential oil
of Thymus vulgaris w a st e s t e do nh e a da n dn e c ks q u a m o u s
cell carcinoma (HNSCC) by Sertel et al. [15] and was found
to have a very low toxicity with an IC50 value of 369μg/mL.
The positive control actinomycin D showed an IC50 value of
0.027 ±0.00021μg/mL.
Extracts which showed SI values equal or greater than
one were chosen for further mechanistic studies. From
the SI values summarized in Table 2 it was noted that
Origanum vulgare and Laurus nobilis had SI values which
were greater than one. When considering the aﬀectivity of
these extracts on HeLa cells it was noted that Laurus nobilis
had the highest toxicity, whereas Origanum vulgare had a
much lower toxicity. When considering the toxicity of these
extracts towards the Vero cells, it is preferred that there is
very low toxicity as these cells are used as a comparison
to normal human cells. Origanum vulgare had the lowest
toxicity, whereas Laurus nobilis had a slightly higher toxicity.
Both these extracts were chosen for further mechanistic
studies due to their SI values; however Origanum vulgare
is not very eﬀective against the HeLa cell line. However in
a study conducted by Al-Kalaldeh et al. [16] the volatile
oil extract of Origanum vulgare was very eﬀective against
human breast adenocarcinoma cells (MCF7) with an IC50 of
30.1 ± 1.14μg/mL. In the same study an ethanolic extract of
Laurus nobilis showed an IC50 of 24.49μg/mL.
3.3. Light Microscopy. Laurus nobilis and Origanum vulgare
were qualitatively analyzed at their IC50 and 2IC50 values
to investigate their inﬂuence on the HeLa cells and on the
Vero cells. The mechanism of action of both extracts was
determined by observing the change in cell morphology
after the exposure of the cell lines to the extracts and
comparing them to vehicle-treated controls and medium
controls. In Figures 2(a) and 2(b) where the cells were
propagated in medium and in the presence of DMSO
(vehicle-treated), respectively, normal proliferation seemed
to take place and typical morphology was observed. In
Figure 2(a)anaphaseandinterphasewasobservedwhereasin
Figure 2(b) metaphase and interphase was observed, which
aretypicalcharacteristicsofthecellcycle.HoweverinFigures
2(c) and 2(d) normal cell proliferation was absent and signs
of cell death and growth disorders started to appear. In
these photographs the HeLa cells were exposed to the IC50
and 2IC50 values of Laurus nobilis extract. In both these
photographs typical morphological features of apoptosis
started to appear such as hypercondensed chromatin and
the degredation of DNA. The positive control actinomycin
D also showed features of apoptosis, such as the presence of
apoptotic bodies (Figure 2(e)).
Observing the Vero cells in the absence and presence of
Laurus nobilis and actinomycin D (Figure 3) similar mor-
phological changes were seen as in Figure 2. When the cells
were grown in medium only and in the presence of DMSO
normal cell proliferation took place such as metaphase
(Figures 3(a) and 3(b)) and interphase (Figure 3(a)). In
the photographs where the cells were exposed to the IC50
and 2IC50 values of Laurus nobilis changes in cellular
morphology started to take place. In both Figures 3(c) and
3(d) cellular debris was observed which could be as a result
of lysis of apoptotic bodies. Furthermore the presence of
hypercondensed chromatin was seen in Figure 3(d). In the
presence of actinomycin D (Figure 3(f)) hypercondensed
chromatin was also visible. An important observation was
madeinFigure 3(e)wheretheVerocellsweretreatedwiththe
IC50 dose of Laurus nobilis on HeLa cells. In this photograph
normal proliferation took place as seen by the presence
of metaphase. It was important to observe that the Vero
cells revealed less prominent features of cell death when
they were treated at the IC50 of Laurus nobilis on HeLa
cells.
In the HeLa cell line when the cells were grown in
medium only and exposed to DMSO, normal cell cycle mor-
phology was viewed. In Figure 4(a) anaphase was observed
whereas in Figure 4(b) cytokinesis was observed, which is
the last step in normal cell cycle before two daughter cells
are formed. In Figures 4(c) and 4(d) when cells were treated
at the IC50 and 2IC50 values of Origanum vulgare,a p o p t o t i c
morphological features were viewed such as hypercondensed
chromatin and in the presence of actinomycin D apoptotic
bodies were observed. Therefore when HeLa cells were
treated with the Origanum vulgare extract there was an
increase in morphological features which correlated with
apoptosis.
In the Vero cell line, vehicle-treated controls (Figure
5(b)) and medium-only controls (Figure 5(a))w e r ev i a b l e
and still showed signs of proliferation as seen by the
presence of metaphase in both photographs. Actinomycin
D( Figure 5(f)) as well as cells treated with 163.8μg/mL
and 327.6μg/mL of the Origanum vulgare extract (Figures
5(c) and 5(d)) showed prominent signs of cell death occur-
ring through apoptosis such as hypercondensed chromatin.
In Figure 5(e) where the Vero cells were treated with
126.3μg/mL of Origanum vulgare normal cell proliferation
took place where anaphase was observed. This concentration
is where 50% of the HeLa cells were inhibited by the extract,
but showed less prominent and negligible signs of toxicity to
the noncancerous cell line.
3.4. Confocal Microscopy. Change in morphological features
when the cancerous (HeLa) and noncancerous (Vero) cell
lines were exposed to various concentrations of the acetone
extracts of Laurus nobilis and Origanum vulgare were con-
ﬁrmed when visualizing the cells under confocal microscopy.
The HeLa cells showed normal signs of cell proliferation
w h e ng r o wni nm e d i u mo n l yo rw h e ne x p o s e dt o2 %D M S O
as seen in Figures 6(a) and 6(b) respectively. Normal cell
growth and proliferation was conﬁrmed by the presence
of metaphase and anaphase. Actinomycin D (Figure 6(e))
showed clear signs of cell death with the presence of
hypercondensed chromatin. Laurus nobilis treated HeLa cells
revealed an increase in morphological features which were
characteristic of apoptosis, which included the presence of
hypercondensed chromatin and reduced cytoplasm (Figures
6(c) and 6(d)). The reduction in cytoplasm could have
been due to the detachment of cells during the time of
incubation.6 Evidence-Based Complementary and Alternative Medicine
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Figure 2: Haematoxylin and eosin staining of HeLa medium only control cells (a), vehicle-treated control cells (b), 34.46μg/mL Laurus
nobilis treated cells (c), 68.92μg/mL Laurus nobilis treated cells (d), and 0.05μg/mL actinomycin D (e), after 72h of exposure (400x
magniﬁcation).
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Figure 3: Haematoxylin and eosin staining of Vero medium only control cells (a), vehicle-treated control cells (b), 124.1μg/mL Laurus
nobilis treated cells (c), 248.2μg/mL Laurus nobilis treated cells (d), 34.46μg/mL Laurus nobilis treated cells (e), and 0.05μg/mL actinomycin
D (f), after 72h of exposure (400x magniﬁcation).Evidence-Based Complementary and Alternative Medicine 7
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Figure 4: Haematoxylin and eosin staining of HeLa medium only control cells (a), vehicle-treated control cells (b), 126.3μg/mL Origanum
vulgare treated cells (c), 252.6μg/mL Origanum vulgare treated cells (d), and 0.05μg/mL actinomycin D (e), after 72h of exposure (400x
magniﬁcation).
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Figure 5: Haematoxylin and eosin staining of Vero medium only control cells (a), vehicle-treated control cells (b), 163.8μg/mL Origanum
vulgare treated cells (c), 327.6μg/mL Origanum vulgare treated cells (d), 126.3μg/mL Origanum vulgare treated cells (e), and 0.05μg/mL
actinomycin D (f), after 72h of exposure (400x magniﬁcation).8 Evidence-Based Complementary and Alternative Medicine
Metaphase
(a)
Interphase
(b)
Hypercondensed
chromatin
(c)
Hypercondensed
chromatin
Reduced cytoplasm
(d)
Hypercondensed
chromatin
(e)
Figure 6:Hoechst33342andpropidiumiodidestainingofHeLamediumonlycontrolcells(a),vehicle-treatedcontrolcells(b),34.46μg/mL
Laurus nobilis treated cells (c), 68.92μg/mL Laurus nobilis treated cells (d), and 0.05μg/mL actinomycin D (e), after 72h of exposure (1000x
magniﬁcation).
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Figure 7: Hoechst 33342 and propidium iodide staining of Vero medium only control cells (a), vehicle-treated control cells (b), 124.1μg/mL
Laurus nobilis treated cells (c), 248.2μg/mL Laurus nobilis treated cells (d), 34.46μg/mL Laurus nobilis treated cells (e), and 0.05μg/mL
actinomycin D (f), after 72h of exposure (1000x magniﬁcation).Evidence-Based Complementary and Alternative Medicine 9
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Figure 8: Hoechst 33342 and propidium staining of HeLa medium only control cells (a), vehicle-treated control cells (b), 126.3μg/mL
Origanum vulgare treated cells (c), 252.6μg/mL Origanum vulgare treated cells (d), and 0.05μg/mL actinomycin D (e), after 72h of exposure
(1000x magniﬁcation).
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Figure 9: Hoechst 33342 and propidium iodide staining of Vero medium only control cells (a), vehicle-treated control cells (b), 163.8μg/mL
Origanum vulgare treated cells (c), 327.6μg/mL Origanum vulgare treated cells (d), 126.3μg/mL Origanum vulgare treated cells (e), and
0.05μg/mL actinomycin D (f), after 72h of exposure (1000x magniﬁcation).10 Evidence-Based Complementary and Alternative Medicine
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metaphase (Figure 7(a)) and anaphase (Figure 7(b))w e r e
observed indicating that there were no growth deformities.
However in Figures 7(c) and 7(d) changes in morphology
started to appear such as the presence of hypercondensed
chromatin and cellular debris. Furthermore in the pres-
ence of actinomycin D apoptotic bodies started to appear
(Figure 7(f)). However in Figure 7(e) normal cell cycle
features were viewed such as metaphase which indicates that
attheIC50 concentrationofLaurusnobilisonHeLacellsthere
were less prominent cellular features of cell death on Vero
cells.
In the presence and absence of Origanum vulgare on
HeLa cells diﬀerent morphological features were observed.
In untreated cells or cells treated with 2% DMSO promi-
nent features corresponding with normal cell growth and
proliferation was observed, which included metaphase
(Figure 8(a)) and interphase (Figure 8(b)). However in cells
treated with 126.3μg/mL and 252.6μg/mL of Origanum
vulgare severe signs of cell death were viewed. In cells
treated with an IC50 concentration features such as reduced
cytoplasm and fragmented DNA was seen (Figure 8(c)),
whereas in cells treated at a 2IC50 concentration features
appeared such as hypercondensed chromatin and cellular
membrane blebbing (Figure 8(d)). These features tend to
be characteristics of apoptotic cell death. Actinomycin D
(Figure 8(e)) showed similar signs of apoptosis with the
appearance of hypercondensed chromatin.
Verocellsshowednormalcellproliferationwhenexposed
to medium only or 2% DMSO treated cells. Cell cycle
features such as metaphase (Figure 9(a)) and interphase
(Figure 9(b)) were observed. Cells exposed to IC50 and 2IC50
concentrations showed distinct signs of apoptosis such as
hypercondensed chromatin (Figures 9(c) and 9(d))a n d
cellular membrane blebbing (Figure 9(d)). In Figure 9(e)
normal cell proliferation was observed as seen by the
presenceofmetaphase.ActinomycinDalsoshowedmorpho-
logicalfeatureswhichwerecharacteristicofapoptosissuchas
apoptotic bodies (Figure 9(f)).
The two microscopy techniques were in agreement
with one another. The haematoxylin and eosin staining is
based on diﬀerentiating the nuclei from the cytoplasm. The
haematoxylin stains the nuclei blue/purple whereas the eosin
stains the cytoplasm red. The confocal microscopy is based
on diﬀerentiating intact cells from those that have lost their
membrane integrity. The Hoechst 33342 penetrates intact
cell membranes of viable cells and those undergoing apop-
tosis and therefore stains the nucleus. Propidium iodide can
only stain the nucleus of cells that have lost their membrane
integrity and therefore stain the nucleus of cells undergoing
late apoptosis and necrosis [9]. In both cell lines the extracts
showed morphological changes including apoptotic bodies,
hypercondensed chromatin, reduced cytoplasm, and cellular
debris which were indicative of possible apoptosis taking
place [17, 18]. In the HeLa cell line the common feature of
apoptosis occurring washypercondensedchromatin whereas
in the Vero cell line cellular debris as well as hypercondensed
chromatin seemed to occur more often.
4. Conclusion
In this study common herbs and spices were chosen to
determine their anticancer activity. Herbs and spices were
chosen due to their bioactive components which have
the ability to reduce the risk of cancer through their
antimicrobial, antioxidant, and antitumourogenic activity
[19]. The rosemary species were found to have the highest
antioxidant content which could be attributed to the high
contentofpolyphenoliccompounds.Thereforetherosemary
species possess potential chemopreventive properties. After
performing the XTT cytotoxicity assay it was hypothesized
that Laurus nobilis, with an SI of 3.61, and Oregano vulgare,
with an SI of 1.30, were the best candidates for further
investigation. Both these extracts were further investigated
to determine their mechanism of cell death by observing
themunderlightmicroscopyandconfocalmicroscopy.From
the microscopy images it was observed that in both cell
lines morphological changes did appear after exposure to
various concentrations of the acetone extracts. Although
thesemicroscopyimageswereinagreementwithoneanother
that apoptosis was the possible mechanism of cell death,
as seen by the characteristic features of hypercondensed
chromatin (mostly in HeLa cells) and cellular debris (seen
onlyinVerocells),theyarenotsuﬃcientenoughtodeﬁnitely
conﬁrm that apoptosis is taking place and therefore more
sensitive assays such as ﬂow cytometry need to Be used
to conﬁrm that apoptosis is taking place. However Laurus
nobilis did show promising results as an anticancer agent due
to its relatively high toxicity on the HeLa cell line and at this
same concentration a low toxicity on the Vero cell line.
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